Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2014; 20(15): 4316-4328
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4316
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4316
Figure 5 Sendai virus/dF/Far up stream element-binding protein-interacting repressor vector showed anti-tumor activity in a mouse xenograft model.
106 Yes-5 cells were xenografted into the right thigh of Balbc/nu/nu mice, and the tumor size was approximately 15 mm in diameter at Day 0. 3.0 × 107 CIU of SeV/dF/FIR vectors were injected directly around the tumor every two days, seven times in total. Tumor growth was observed and measured every two days as described in Materials and Methods. Ulcer formation was observed in the center of the tumor (day 14 after SeV/dF/FIR injection). Tumor size was significantly diminished with ulcer formation (day 90) and disappeared completely during surveillance (day 140). Thick arrows in the images indicate the tumor margin. Thin arrows indicate the injection of SeV/dF/FIR vectors into the tumor. FIR: FBP Interacting Repressor; FBP: FUSE-Binding protein; FUSE: Far Upstream Element; SeV: Sendai virus; CIU: Cell-infectious units.
-
Citation: Matsushita K, Shimada H, Ueda Y, Inoue M, Hasegawa M, Tomonaga T, Matsubara H, Nomura F. Non-transmissible Sendai virus vector encoding
c-myc suppressor FBP-interacting repressor for cancer therapy. World J Gastroenterol 2014; 20(15): 4316-4328 - URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4316.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i15.4316